Moyamoya Disease Treatment
Moyamoya Disease Treatment
Because nothing has been shown to stop the narrowing, the treatment that changes the situation is surgical: bring blood to the surface of the brain from a vessel outside the skull. There are two ways to do it, and they differ in the one thing patients care about — how quickly the new supply arrives. A direct bypass stitches an artery from the scalp to an artery on the brain and adds flow immediately. An indirect procedure lays vascularised tissue against the brain and waits for new vessels to grow into it, which takes weeks to months. Most adults are treated with both.
What medication does, and what it cannot do
This is the first thing to establish, because the answer is unambiguous and it shapes everything after it. No drug has been shown to stop the narrowing from progressing. Medicines are used in this condition, and they are useful, but they treat the consequences rather than the vessel.
Antiplatelet therapy is used in selected patients with ischaemic symptoms, on the reasoning that a narrowed vessel is a place where a clot can form; the evidence for it is limited, and it is not given without thought in a patient who has bled, because the same drug works against bleeding. Calcium channel blockers and other agents are used for headache, and the evidence for them is weaker still. Blood pressure is treated because it bears on both risks. None of these changes the calibre of the carotid artery.
Saying this plainly matters, because patients are frequently given medicines and left with the impression that they are being treated. They are being treated for the effects of the disease while the disease continues. The intervention that adds flow to the brain is surgery, and the realistic way to frame the choice is not medication versus surgery but medication alongside surgery, or surgery deferred with a plan and a follow-up date.
Direct bypass: flow that arrives today
In a direct anastomosis the superficial temporal artery — a branch of the external carotid that runs across the temple and can be felt at the hairline — is dissected free and sewn to a cortical branch of the middle cerebral artery on the surface of the brain, through a small opening in the skull. The connection is microscopic work on vessels that in a child may be a millimetre or two across. When the clamps come off, flow is increased immediately.
That immediacy is its advantage and the source of its principal risk. A territory that has been chronically under-perfused receives, within seconds, a supply it has not had for years, and the small vessels there have lost the ability to regulate. The result can be cerebral hyperperfusion: headache, seizures, and in a minority of patients bleeding into a territory that was ischaemic yesterday. It is anticipated rather than discovered, blood pressure is managed tightly in the first days, and it is the reason the operation is performed in a centre that expects to see it.
The anatomical limit is real: the operation requires a recipient vessel of adequate calibre on the brain's surface. In a very young child the vessels may be too small for a reliable anastomosis, which is one of the reasons indirect procedures, or staged surgery, are preferred in the youngest patients. The other limit is the territory: a single anastomosis supplies the region it reaches, and the disease is bilateral.
Indirect revascularisation: vessels that grow in
An indirect procedure does not connect anything. Instead, tissue that carries its own blood supply is laid against the surface of the brain, and over the following weeks and months new vessels grow across from it into the brain. Several tissues are used and the operations are named for them: a flap of dura, the temporalis muscle, the pericranium, or combinations of these. Burr holes — small openings in the skull — are sometimes added so that vessels can cross through them as well.
The advantages are that the technique is surgically simpler, that it does not require a recipient vessel of a given size, and that it is therefore applicable to small children in whom a direct anastomosis is not feasible. It is also the safer operation in the immediate sense: because flow increases gradually, hyperperfusion is far less of a problem.
The disadvantage is the wait. New vessel growth takes weeks to months, and until it has happened the patient is not protected — the transient attacks can continue, and a stroke can occur in the interval. The eventual increase in flow is also generally less than a direct bypass delivers, and the process does not succeed in every patient. Parents of a child having this operation should be told the honest timetable: the operation is the beginning of the treatment, and the benefit accrues over the months after it.
Doing both, and doing both sides
Combined revascularisation performs a direct anastomosis and an indirect procedure at the same operation. The direct component provides flow immediately; the indirect component continues to develop a broader supply over the months that follow. In adults this is the commonest shape of surgery, and it is a reasonable way of understanding why: an adult cannot wait months for protection, and a single anastomosis does not cover enough territory.
The second thing to prepare for is that the disease is bilateral, so most patients need surgery on both sides. The two operations are staged rather than performed together, with an interval of weeks to months between them, and the more symptomatic side is usually done first. A family should be told this at the outset, because the discovery that a second operation is needed comes as a surprise far more often than it should.
The part that is not the operation
In moyamoya surgery the anaesthetic and the days afterwards are as consequential as the anastomosis, because the two things that cause harm are both avoidable. The first is hypocapnia: hyperventilation lowers carbon dioxide and constricts the very vessels that are already narrowed. A child who arrives crying, and who hyperventilates during induction, can become ischaemic before the operation begins. Carbon dioxide is therefore held deliberately normal, and induction is managed with that in mind.
The second is hypovolaemia. A patient with exhausted reserve cannot compensate for dehydration, and a child who has been fasting before surgery is a child whose supply is marginal. Fluids are maintained through the perioperative period, and fever is treated promptly, for the same reason.
After surgery the concern inverts, particularly after a direct bypass. Blood pressure is managed within a defined range rather than simply kept normal, seizures are anticipated and treated, and a new or worsening headache is investigated rather than observed. Antiplatelet therapy is continued through the period in which the new vessels are establishing. Most patients spend a few days in a monitored setting after an uncomplicated operation.
After it has bled
The immediate work is the bleed itself: controlling pressure, managing blood in the ventricles where it has extended there, and treating the consequences. Alongside that, one question is answered early, because it determines what happens next — where the blood came from. If an aneurysm is found on a collateral or perforating vessel, it is treated on its own account, and the revascularisation is planned around it rather than after it.
Where no aneurysm is found, and the bleeding came from the fragile collateral vessels themselves, revascularisation is discussed for a different reason: reducing the chance that it happens again. The randomised trial conducted in adults who had already bled compared bypass with medical treatment and found rebleeding to be less frequent in the surgical group over the period studied. That is an argument for discussing surgery, and it is not the same as a guarantee — the operation reduces the risk, and a revascularised patient can still bleed from a vessel the surgery did not address.
Timing after a bleed is individual. The acute phase is managed first, and revascularisation is usually undertaken once the patient has stabilised and the immediate consequences have settled, rather than during the admission for the bleed. Where an aneurysm is present and has been secured, the interval is often shorter.
What surgery does to a life, and what it does not
Revascularisation changes the blood supply, and for most patients it stops the attacks. What it does not do is undo the deficits that accumulated before it: a child who has had several infarcts does not recover what those cost, and an adult who has bled has rehabilitation ahead of them. This is the strongest argument in the whole condition for acting before the next event rather than after it.
Recovery also has a shape that is worth knowing in advance. The first weeks carry the surgical risk and the hyperperfusion concern; the months after an indirect procedure are the period in which the new supply establishes itself, and during which attacks can still occur. Follow-up imaging confirms whether the new vessels have developed, and perfusion studies can be repeated to show what the reserve now is. In children, follow-up includes development and school performance, because that is where the untreated disease does its quietest damage.
And the follow-up does not end. The disease progresses in vessels that have not been revascularised, the other side usually needs surgery, and a territory that has been treated still requires confirmation that the supply has held. A patient who has had surgery is not a patient who has been discharged from the condition.